ENTRY       D01907                      Drug
NAME        Fludarabine phosphate (JAN/USP);
            Fludara (TN)
PRODUCT
  GENERIC   FLUDARABINE (Fresenius Kabi USA)
            FLUDARABINE PHOSPHATE (Actavis Pharma)
            FLUDARABINE PHOSPHATE (Areva Pharmaceuticals)
            FLUDARABINE PHOSPHATE (Lannett Company)
            FLUDARABINE PHOSPHATE (Sagent Pharmaceuticals)
FORMULA     C10H13FN5O7P
EXACT_MASS  365.0537
MOL_WEIGHT  365.2117
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01439  Arabinofuranosyl type antineoplastic
REMARK      Therapeutic category: 4229
            ATC code: L01BB05
            Chemical structure group: DG00685
            Product (DG00685): D01907<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   B-cell chronic lymphocytic leukemia [DS:H00005]
COMMENT     Active form of prodrug: Fludarabine [DR:D07966]
TARGET      RRM1 [HSA:6240] [KO:K10807]
            DNA polymerase
            RNA polymerase
  PATHWAY   hsa00230(6240)  Purine metabolism
            hsa00240(6240)  Pyrimidine metabolism
INTERACTION  
STR_MAP     map07041  Antineoplastics - antimetabolic agents
            map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BB Purine analogues
                 L01BB05 Fludarabine
                  D01907  Fludarabine phosphate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Fludarabine
                D01907  Fludarabine phosphate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4229  Others
                 D01907  Fludarabine phosphate (JAN/USP)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 DG00685  Fludarabine
                  D01907  Fludarabine phosphate
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D01907  Fludarabine phosphate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Ribonucleoside-diphosphate reductase
                RRM1
                 D01907  Fludarabine phosphate (JAN/USP) &lt;JP/US&gt;
            Prodrugs [br08324.html]
             D01907
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 DG00685  Fludarabine
DBLINKS     CAS: 75607-67-9
            PubChem: 7848969
            ChEBI: 63599
            LigandBox: D01907
            NIKKAJI: J535.382C
ATOM        24
            1   C1y C    11.4800  -11.6200
            2   C1y C    12.8800  -11.6200
            3   C1y C    13.3126  -10.2885
            4   O2x O    12.1800   -9.4656
            5   C1y C    11.0474  -10.2885
            6   O1a O    10.7800  -12.8324
            7   O1a O    13.5800  -12.8324
            8   N5x N    15.7375  -11.6885
            9   C8y C    15.7375  -10.2885
            10  N4y N    14.5251   -9.5885
            11  C1b C     9.8349   -9.5885
            12  O2b O     8.6225  -10.2885
            13  C8y C    16.9499  -12.3885
            14  N5x N    18.1624  -11.6885
            15  C8y C    18.1624  -10.2885
            16  C8y C    16.9499   -9.5885
            17  N5x N    16.6589   -8.2191
            18  C8x C    15.2665   -8.0727
            19  N1a N    19.3497   -9.6027
            20  X   F    16.9499  -13.7900
            21  P1b P     7.2225  -10.2885
            22  O1c O     5.8225  -10.2885
            23  O1c O     7.2225   -8.8901
            24  O1c O     7.2225  -11.6899
BOND        26
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     1   6 1 #Down
            7     2   7 1 #Up
            8     8   9 1
            9     9  10 1
            10    3  10 1 #Up
            11    5  11 1 #Up
            12   11  12 1
            13    8  13 2
            14   13  14 1
            15   14  15 2
            16   15  16 1
            17    9  16 2
            18   16  17 1
            19   17  18 2
            20   18  10 1
            21   15  19 1
            22   13  20 1
            23   12  21 1
            24   21  22 1
            25   21  23 2
            26   21  24 1
///
